Centene (STU:QEN) ROCE %: 22.44% (As of Mar. 2026)


STU:QEN Centene Corp STU:QEN
73 GF Score
Price €57.20
GF Value €72.73
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Centene ROCE %?

Centene STU:QEN +0.39% 73 ROCE % is 22.44% as of Mar. 2026. GuruFocus rates STU:QEN with a GF Score™ of 73/100 and a GF Value™ of €72.73 (Modestly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Centene's annualized ROCE % for the quarter that ended in Mar. 2026 was 22.44%.

Centene  (STU:QEN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Centene ROCE % Related Terms

Centene ROCE % Historical Data

* Premium members only.

The historical data trend for Centene's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centene ROCE % Chart

Centene Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.14 5.38 8.84 10.53 -12.88

Centene Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.38 -0.68 -56.59 -13.51 22.44
STU:QEN
73GF Score
Centene Corp STU:QEN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centene ROCE % Calculation

Centene's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-5166.7/( ( (78734.975 - 32719.255) + (65541.938 - 31338.384) )/ 2 )
=-5166.7/( (46015.72+34203.554)/ 2 )
=-5166.7/40109.637
=-12.88 %

Centene's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=7829.98/( ( (65541.938 - 31338.384) + (70216.375 - 34638.925) )/ 2 )
=7829.98/( ( 34203.554 + 35577.45 )/ 2 )
=7829.98/34890.502
=22.44 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 22.44% mean?
Centene (STU:QEN) has a ROCE % of 22.44% as of Mar. 2026.
Is Centene's ROCE % too high?
Centene's current ROCE % is 22.44%. The Healthcare Plans industry median ROCE % is 9.38. Centene's value of 22.44% is 139.2% above this industry median. Overall, Centene has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centene's ROCE % compare to HUM and MOH?
Centene's ROCE % of 22.44% can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 9.38. Centene's value of 22.44% is 139.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Plans company?
The median ROCE % among Healthcare Plans companies is 9.38, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centene's current ROCE % of 22.44% is 139.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centene's current ROCE % is 22.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centene stock overvalued right now?
Based on GuruFocus' analysis, Centene (STU:QEN) is currently considered Modestly Undervalued. The stock's GF Value™ is €72.73, compared to a current price of €57.20 — trading 21.4% below its estimated fair value. The current ROCE % is 22.44% and 139.2% above the Healthcare Plans industry median of 9.38. Centene's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Centene (STU:QEN), the current ROCE % is 22.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centene (STU:QEN) Overvalued in 2026?

Based on GuruFocus' analysis, Centene stock appears to be undervalued. The current stock price of €57.20 is trading 21.4% below its estimated GF Value™ of €72.73. GuruFocus considers Centene to be Modestly Undervalued.

Key valuation signals for STU:QEN:

  • ROCE %: 22.44%
  • GF Value™: €72.73 vs. price of €57.20 (21.4% below fair value)
  • GF Score™: 73/100 with 7 warning signs
  • Industry Position: 139.2% above the Healthcare Plans median

No single metric tells the full story. See the STU:QEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centene Business Description

Address 7700 Forsyth Boulevard, St. Louis, MO, USA, 63105
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
73GF Score

Get the complete analysis for STU:QEN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.20
Price
€72.73
GF Value